Preventing diabetes by treating aspects of the metabolic syndrome (Q35087545)

6 August 2017

1 reference

title

Preventing diabetes by treating aspects of the metabolic syndrome (English)

1 reference

6 August 2017

1 reference

Roopa Sathyaprakash

1 reference

6 August 2017

Robert R Henry

series ordinal

1 reference

6 August 2017

language of work or name

1 reference

1 October 2002

1 reference

6 August 2017

published in

Current diabetes report

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

416-422

1 reference

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

6 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-002-0106-2

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-002-0106-2

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

12 December 2020

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

12 December 2020

The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

1 reference

12 December 2020

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

1 reference

12 December 2020

Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study

1 reference

12 December 2020

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Diabetes. Exploding type II.

1 reference

12 December 2020

Insulin causes endothelial dysfunction in humans: sites and mechanisms.

1 reference

12 December 2020

The Whitehall Study: Ten Year Follow-up Report on Men With Impaired Glucose Tolerance With Reference to Worsening to Diabetes and Predictors of Death

1 reference

12 December 2020

ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension

1 reference

12 December 2020

Ramipril and the development of diabetes.

1 reference

12 December 2020

Impaired glucose tolerance--prevalence and conversion to NIDDM.

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

12 December 2020

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

1 reference

12 December 2020

ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide.

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

10.1007/S11892-002-0106-2

Identifiers

DOI

1 reference

6 August 2017

1 reference